Lv54
1090 积分 2023-08-21 加入
Successes and failures: the latest advances in the clinical development of amyloid–β–targeting monoclonal antibodies for treating Alzheimer's disease
8天前
已完结
8 Oral: ALTA3263: an oral, KRAS isoform-selective, dual ON/OFF state, noncovalent inhibitor induces regressions across KRAS G12V, G12D, and G12C cancer models
10天前
已完结
Strategic Approaches to Improvise Peptide Drugs as Next Generation Therapeutics
16天前
已关闭
Strategies to Optimize Peptide Stability and Prolong Half-Life
16天前
已完结
A Review on the Metabolism of 25 Peptide Drugs
16天前
已完结
The TBL1 inhibitor, Tegavivint, suppresses tumour growth and enhances T-cell infiltration in preclinical murine β-Catenin mutant hepatocellular carcinoma
1个月前
已完结
Organoboron Mediated Homolytic Aromatic Substitution of N-Methoxypyridinium Salts
1个月前
已关闭
Current advances and development strategies of targeting son of sevenless 1 (SOS1) in drug discovery
1个月前
已完结
Inhibition of Son of Sevenless Homologue 1 (SOS1): Promising therapeutic treatment for KRAS-mutant cancers
1个月前
已完结
Targeting RAS oncogenesis with SOS1 inhibitors
1个月前
已完结
皖公网安备34019202002308
